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Abstract: Arthrosclerosis considered one of the most important causes of morbidity and mortality in industrial 
and developing countries. The rate of myocardial infarction in some countries is about 2 million annually with 
1 /4 of them is leading to death. This study was a case-control research, which was carried out as cross-sectional 
project in two groups, healthy and case subjects. The mean age and standard deviation of patients and control 
groups were nearly equal (55±10). The ELISA technique was applied to measure the serum antibody level. The 
sample populations in each group were exactly the same (120 person in each group). The gender distribution in case 
and control group was 44 female, 76 male and 45 female and 75 male, respectively. The Mean±SD of IgM in case 
group and control groups were 3.10± 2.54 and 1.54±1.00, respectively. The Mean±SD for IgG in case and control 
groups were 5.90±3.84 and 3.08±1.95, respectively. The differences, between the mean ofigM and IgG in two groups 
of cases and control statistically were significant (p = 0.0001 ). In case group the Mean±SD for IgM for men and 
woman were 2.98±1.97 and 3.17±2.83, respectively, which this differences statistically, were not significant. In case 
group the Mean±SD for IgG were 5.14±3.45 and 6.35. The above findings indicated that the average of both IgG and 
IgM are higher among men compared to women. Due to high prevalence of acute coronary syndrome in Iran, the 
determination of anticardiolipin antibody (IgG) are applied for suspected acute coronary syndrome patients and further 
prevention measure should be taken for patient with higher serum anticardiolipin antibody. 
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INTRODUCTION 
Arthrosclerosis considered being one of the most 
important causes of morbidity and mortality in industrial 
and developing countries. The rate of myocardial 
infarction in U.S. is about 2 million annually with 1 /4 of 
them is leading to death (Cannon, 2003, El-Sayed et al., 
2007). The prevalence of coronary vascular disease in 
central Iran is about 9.3%. It is reported that 38% of all 
death in Iran are due to heart diseases. The reasons 
behind arthrosclerosis are genetically related, acquired 
risk factors, such as high blood cholesterol. Due to 
nutritional habitual; high blood pressure, obesity, 
diabetes, cigarettes smoking, low physical activity, some 
inflammatory mechanisms can disrupt the regulation of fat 
within the vain and initiate the arthrosclerosis lesion 
(Sherer and Shoenfeld, 2002). The recent studies indicate 
the role plagued by immunological responses in induction 
of arthrosclerosis. These latest response include the 
chemical component of CRP, other infectious agents, such 
as Chlamydia pneumonia and autoantibodies. The various 
auto-antibodies genes, which can cause and mediate the 
cardiovascular disease, are including cardiolipin, OXLDL, 
β2GP1 and HSP (Jara et al., 2006; Su et al., 2006). 
Antiphospholipids immunoglobulin is examples of such 
autoantibodies. These autoantibodies can be found in healthy 
subjects as well but their concentration are low and are found 
partially is short period of time with the individual blood 
circulation. The phospholipid autoantibodies of non-
autoimmune origin are seen in such disorder as HIV and in 
some cancers (George et al., 1997; Salehi and Mirzaei, 2007; 
Jara et al., 2006). 
The majority of phospholipid antibodies are seen in 
a one autoimmune antibody named, Antibody 
Phospholipid Syndrome (APS). The other characteristic of 
APS are thromboembolic and pregnancy abortions. 
The APS considered as mediator of autoimmunity and 
arthrosclerosis (George and Shoenfeld, 1997). The 
antiphospholipids are integrated with various forms of 
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cardiovascular  diseases,  such  as  myocardial  infractions. 
(Sherer and Shoenfeld, 2003; Vaarala et al., 1995). Anti 
Cardiolipin  Antibody  (ACA)  is  an antibody raised 
against   cardiolipin   and   in   disease   such   as   APS, 
autonomous abortion, thrombosis  and lupus. 
Anticardiolipin    antibody   can   be   divided   into   two 
categories;   1) class-I:   of Immunoglobulin   M   (IgM). 
Immunoglobulin G  (IgG), Immunoglobulin A (IgA. 2) 
Dependent o r  non-dependent t o  β-2-glycoprotein.  This 
test is requested when the signs of a traumatic accident, 
such as pain, inflammation in lower organs, respiratory 
disorder, accompanied with pain are indicated. It is also 
advised   on repeated   pregnancy   abortion   and   lupus. 
Considering   the  high   scale  of  acute  coronary   heart 
diseases and in particular acute myocardial infraction and 
possible role played by anticardiolipin in acute coronary 
syndromes (Erkkila et al., 2005, Levine and Jacobs, 2001; 
Sherer and Shoenfeld, 2003, Wu et al., 1997; Sherer et al., 
2001) and particularly due to the absence of a documented 
para clinical tests and reference into the relation between 
cardiovascular  disorders  and the  blood  antibody  level, 
this  present  research  project  was  designed  to  address 
such queries in this region of northern Iran. 
MATERIALS AND METHODS 
Type of research: This study was a case control study 
which was cross-sectionally carried out in two groups. 
Due to technical difficulties and the absence of other 
types of heart diseases, the sample population in the case 
groups predominantly were from those patients with acute 
myocardial infarctions. 
Method of sampling: On the base of statistical parameter 
the exact number of patient was calculated to be 116 but 
for sake of security and avoiding any mistake 120 
patients were selected. Ethical procedure was applied in 
this study and all patients were informed on the study 
procedure and the patients entered in this on their own 
choice. All the patients were matched on such variables 
as, age and  gender. 
Data collection: A questioner was used for every patient, 
clinical   examination   and   serological    measurement 
was done by cardiologist and clinical laboratory. The 
information within the questionnaires, the medical 
examination   files, laboratory tests, were arranged and 
entered into SPSS statistical software and presented as a 
tables and figures. The statistical Kolmogorov-Smirnov 
test was used to compare the mean of two antibodies of 
IgM and IgG. 
Statistical analysis: Initially the serum of two antibodies 
of IgG, IgM should have been compared;  therefor the 
normal range and positive results in this study should 
have been determined before the actual measurement 
Kolmogorov-Smirnov test was applied for the 
determination of normal range in this study. Using this 
statistical equation the following results was designed. 
Positive results: 
• >5 GPL mL-1
• >15 MPL mL-1
Normal range: 
• ≤15 MPLmL-1
• ≤15 GPL mL-1
RESULTS 
The mean age and standard deviation of patients 
and control groups were nearly equal (55±10).  The 
sample population in each group was exactly the same 
(120 person in each group). The gender distribution in 
case and control groups were 44 female, 76 male and 
45 female and 7 5 male, respectively. In this study the 
matching among case and control was performed properly 
according to Table 1 and even the gender matching was 
also were established to obtain the proper results. The 
Mean±SD of Immunoglobulin M (IgM) in case group 
and control groups were 3.10±2.54 and 1.54±1.00, 
respectively. The Mean±SD for Immunoglobulin G IgG in 
case and control groups were 5.90±3.84 and 3.08±1.95, 
respectively. The differences, between the mean of IgM 
and IgG in two groups of cases and control statistically 
were significant (p 0.0001). In case group the Mean±SD 
for IgM for men and woman were 2.98±1.97 and 3.1 7±2.83 
respectively which this differences statistically were not 
significant (p 0.697). In case group the Mean±SD for 
IgG were 5.14±3.45 and 6.35±4.01, respectively. The 
above findings indicated that the average of both IgG and 
IgM are higher among men compared to women but this 
Table 1: The matching among case and control in general in one hand and between two genders of male and females 
Sex Count Mean±SD p-value p-value (caset+control) 
Case Female 44 55.29±9.800 0.813 0.99 
Male 76 54.84±10.27 
Total 55.01±10.06 
Control Female 45 55.24±9.700 0.833 
Male 75 54.84±10.37 
Total 54.99±10.09 
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Table 2:  Status of antiphospholipids antibodies of  immunoglobulin G (IgG) and immunoglobulin M  (IgM) among  male and  female  in case and 
Control groups 
Sex
Case Control 
IgM IgG IgM IgG
Female 
Mean 2.98 5.14 1.67 3.06 
N 44.00 44.00 45.00 45.00 
Std.deviation 1.97 3.45 1.23 1.97 
Male 
Mean 3.17 6.35 1.46 3.09 
N 76.00 76.00 75.00 75.00 
Std.deviation 2.83 4.01 0.84 1.95 
Total 
Mean 3.10 5.90 1.54 3.08 
N 120.00 120.00 120.00     120.00 
Std.deviation 2.54 3.85 1.00 1.95 
Table 3: Serum immunoglobulin G (IgG) and   immunoglobulin   M (IgM) concentration  level  among patient  and healthy subjects 
lgG IgM 
Parameters High Normal High Normal 
Case count 
Control count  
p-value 
Odds ratio for group (case/control) 
95% confidence Interval 
Values in brackets are percentage 
12 (10) 
1(0.8) 
<0.002 
13.222 
1.691-103.385 
108 (90) 
119 (99.2) 
13 (10.8) 
1 (0.8) 
<0.001 
14.458 
1.860-112.380 
107 (89.2) 
119 (99.2) 
difference  statistically was  not  meaningful (p 0.095) 
(Table 2). In this research project the serum  IgG  and 
IgM concentration was determined among  case  and  
control groups and the results were tabulated in Table 3 
which is shown that there is a statistically significant 
correlation between patients and healthy subject's 
antibodies  level.  
In control group (Table 2) the Mean±SD of IgM for 
women and men were 1.67±1.23 and 1.46±0.84, 
respectively which    statistically   were   not significant (p 
0.266).  The Mean±SD for were 3 . 0 4 ±1.95 and 
3.06±1.97, which again it was not statistically significant 
(P+0.917). The comparison of mean of IgM and IgG in 
both group of case and control among women and men 
were as follow. 
Women: The Mean±SD for IgM is both case and control 
groups were 2.98±1.97 and 1.67±1.23; these findings 
statistically were significant (p 0.0003). The Mean±SD 
for IgM in both case and control groups were 5.14±3.45 
and 3.06±1.97, respectively; this latter difference 
statistically were significant (p 0.0007). 
Men: The Mean±SD of IgM in both case and control 
group were 3.17±2.83 and 1.46±0.83 which statistically 
were significant (p 0.00001). The Mean±SD for IgM in 
both groups of case and control were 6.35±3.09 and 
3.09±1.95, respectively. 
DISCUSSION 
Acute myocardial infarction and Unstable Angina 
(UA) are among wide range of recognized diseases, 
collectively known   as   acute coronary s yndrome.  The 
pathophysiology of this diseases are due to displace, or 
disruption of atheroma from coronary internal vascular 
system. Acute coronary syndromes are among the most 
common form of sudden death and it is well established 
that about 50% of AMI patients die before reaching to the 
hospitals. Earlier studies on the serum Anticardiolipin 
antibody, level in AMI and its normal range and the 
relationship of this antibody with AMI and related 
morbidity and mortality are found to have contradictory, 
results (Brey et al., 2001; George and Shoenfeld, 1997). 
Our study indicated that there are a significant different 
between the serum cardiolipin antibody of AMI patient 
compared with the control group. In our study we found 
that there is a significant correlation between the Alv1I 
and IgG, IgM serum concentration levels. Also in this 
study we found that Patient/Healthy ratio was found to be 
13.22 and 14.458, for IgG and IgM, respectively compared 
to the subjects which they have normal IgG and IgM 
serum concentration levels. Anticardiolipin antibody is 
considered as a major characteristic of antiphospholipids 
syndrome and in the other hand there is a tendency 
toward thrombosis onset. It is probable, that 
anticardiolipin antibody play an important role in 
occurrence and intensity of AMI due to vascular 
abnormality. 
In a study the effective role of anticardiolipin 
antibody and its relationship with arthrosclerosis in mice 
it was demonstrated that the mice which were immunized 
with anticardiolipin antibody and having the higher, titer 
of anticardiolipin antibody and arthrosclerosis intensity 
were observed among mice compared to control group 
(Sherer and Shoenfeld, 2002; George et al., 1997). In 
agreement   with   our   study    it   is   demonstrated  that 
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higher anticardiolipin antibody serum concentration is 
considered as risk factor, in AMI and in elderly men. (Sherer 
and Shoenfeld, 2002). In separate study on 63 patients 
afflicted with the ACS, which were admitted to the CCU 
during 2003-04, the average anticardiolipin antibody among 
patient were 4.35±2.7 and in the control group it was 3.38
±3.1 which demonstrated to have significant differences (p = 
0.038). This average for men in case and control group were 
4.47±2.22 and 3.08±2.17, respectively which statistically 
were significant (p = 0.002). 
In latter study, there was not a meaningful difference 
among female in case and control group, 4.1±3.58 vs. 3.69± 
3.89 (p = 0.634). The latter finding are in agreement with our 
general population average and also men average but our 
finding about women is contradicted other results, because, in 
our study we found an significant difference among women in 
case and control group (p = 0.0007). In our study we found 
also a statistically significant correlation of higher level of 
IgG and IgM levels among AMI patients which is an 
interesting finding which can be used in laboratory 
investigation for AMI patient clinical setting. Also we should 
mention that in our study we found that there is not 
meaningful correlation between IgG and IgM levels and AMI 
among women but there is a meaningful correlation between 
IgG and IgM serum level and AMI among men, which is an 
interesting finding . 
This disagreement can be explained as follow, in 
Salehi and Mirzaei (2007) study the sample population of 
case and control were not equal 63 vs. 103. The other 
explanation is that, in our study in spite of extra clinical 
and Para clinical examination such as ANA test, we were 
not able to discriminate the coexistence of other disease 
such as lupus but we are in opinion that the former 
possibility can fit these differences. One further clue to 
this disagreement may be relay on the differences on the 
women mean age in case and control group. In other 
study by Ghaemian et al it was demonstrated that there 
was a statistically significant differences between serum 
anticardiolipin antibody among patient with AMI and control 
group (p = 0.01) It was found that there was, a significant 
increase of serum anticardiolipin antibody of AMI patient 
with control group (37.14±30.18 vs. 13.14±3.02) and based 
on their findings it was concluded that anticardiolipin 
antibody serum level can be considered as a risk factor for 
ischemic heart diseases and it is suggested it can be 
considered as marker for the subsequent syndrome vascular 
thrombolytic lesion 
(El-Sayed et al., 2007). The latter findings are in 
agreements with our data from this study, which 
indicated that the AMI patients have high anticardiolipin 
antibody serum level, compared with control group but it 
should mentioned that we measured IgM was measured 
in addition to IgG which was determined by Elsheikh et al. 
(2010 ). 
CONCLUSION 
Based on our finding we can indicate that the mean 
serum level of IgM and IgG were 4.55-0.55 and 9.9- 1.15 
respectively. The sensitivity and specificity for this spectrum 
of reference rang was calculated as 90%. It is concluded that 
due to high prevalence of acute coronary syndrome in Iran 
particularly among men the determination of anticardiolipin 
antibody (IgG, IgM) are to be applied for the suspected acute 
coronary syndrome patients and further prevention measure 
should be taken for the patients with higher serum 
anticardiolipin antibody. 
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